Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 22-1 (TRBV22-1) is a gene segment that encodes one of the variable regions of the beta chain of the T cell receptor (TCR) complex. The TCR is a disulfide-linked membrane protein found on the surface of T lymphocytes (T cells), which recognizes antigenic peptides presented by major histocompatibility complex (MHC) molecules[1][3]. The beta chain of the TCR is generated during T cell development through somatic recombination involving variable (V), diversity (D), and joining (J) gene segments[1][3]. TRBV22-1 is one of many variable (V) gene segments of the TCR beta locus and contributes to the diversity of antigen recognition. Some sources refer to this gene as a pseudogene, indicating that the segment is non-functional in some individuals and does not produce a protein product (hence, alternative names referring to it as a pseudogene)[2]. TCRs play essential roles in the adaptive immune system, enabling T cells to recognize and respond to a wide variety of pathogens[1][3]. Importantly, TRBV22-1 itself, like other individual TCR variable segments, is not considered a direct pharmacological or therapeutic target, nor is it commonly used as a biomarker or known to interact with drugs. Instead, the functional TCR complex as a whole is fundamental in immune cell signaling and antigen-specific immune activation[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 22-1 (TRBV22-1).